Work

Activation of the TLR2-MyD88 pathway is required for in-vivo efficacy of Lipid Nanoparticle based vaccine formulation

Year: 2017

Type: conference-abstract

Source: The Journal of Immunology

DOI: 10.4049/jimmunol.198.supp.79.2

Authors: Gokul Swaminathan, Shu-An Lin, ManishKumar Patel, Katie DiFelice, Jeffrey Smith, Marian Gindy, Ashley Mahne, Daniel Cua, Danilo Casimiro, Amy Espeseth, Andrew Bett

Institution: Merck & Co., Inc., Rahway, NJ, USA (United States)

Language: English

Topic: Immunotherapy and Immune Responses

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2902265442

Cites:

Cited by: 3

Related to: 10